Bacitracin Ophthalmic Ointment — FDA Drug Shortage

Current — Padagis US LLC

The FDA lists a drug shortage record for Bacitracin Ophthalmic Ointment (ophthalmic ointment) from Padagis US LLC with status Current. The shortage was first posted on Mar 3, 2025. Reported reason: Discontinuation of the manufacture of the drug

Shortage details

Status
Current
Company
Padagis US LLC
Package NDC
0574-4022-35
Dosage Form
Ophthalmic Ointment
Presentation
Bacitracin, Ophthalmic Ointment, 3.5 g (NDC 0574-4022-35)
Initial Posting
Mar 3, 2025

Reason

Discontinuation of the manufacture of the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.